Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection
dc.authorid | Tolga Sinan Güvenç / 0000-0002-6738-266X | en_US |
dc.authorscopusid | Tolga Sinan Güvenç / 6602421975 | |
dc.authorwosid | Tolga Sinan Güvenç / AAK-6020-2020 | en_US |
dc.contributor.author | Atıcı, Adem | |
dc.contributor.author | Çalışkan, Mustafa | |
dc.contributor.author | Baycan, Ömer Faruk | |
dc.contributor.author | Çelik, Fatma Betül | |
dc.contributor.author | Güvenç, Tolga Sinan | |
dc.contributor.author | Çağ, Yasemin | |
dc.contributor.author | Konal, Oğuz | |
dc.contributor.author | Bilgili, Ümmühan Zeynep | |
dc.contributor.author | Ağırbaşlı, Mehmet Ali | |
dc.contributor.author | Irgı, Tuğçe | |
dc.date.accessioned | 2022-05-23T08:04:36Z | |
dc.date.available | 2022-05-23T08:04:36Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Background and Aims: Microvascular disease is considered as one of the main drivers of morbidity and mortality in severe COVID-19, and microvascular dysfunction has been demonstrated in the subcutaneous and sublingual tissues in COVID-19 patients. The presence of coronary microvascular dysfunction (CMD) has also been hypothe-sized, but direct evidence demonstrating CMD in COVID-19 patients is missing. In the present study, we aimed to investigate CMD in patients hospitalized with COVID-19, and to understand whether there is a relationship between biomarkers of myocardial injury, myocardial strain and inflammation and CMD.Methods:39 patients that were hospitalized with COVID-19 and 40 control subjects were included to the present study. Biomarkers for myocardial injury, myocardial strain, inflammation, and fibrin turnover were obtained at admission. A comprehen-sive echocardiographic examination, including measurement of coronary flow veloc -ity reserve (CFVR), was done after the patient was stabilized.Results:Patients with COVID-19 infection had a significantly lower hyperemic cor -onary flow velocity, resulting in a significantly lower CFVR (2.0 ± 0.3 vs. 2.4 ± 0.5, p< .001). Patients with severe COVID-19 had a lower CFVR compared to those with moderate COVID-19 (1.8 ± 0.2 vs. 2.2 ± 0.2, p< .001) driven by a trend toward higher basal flow velocity. CFVR correlated with troponin (p= .003, r: ?.470), B- type natriu-retic peptide (p< .001, r: ?.580), C- reactive protein (p< .001, r: ?.369), interleukin-6 (p< .001, r: ?.597), and d- dimer (p< .001, r: ?.561), with the three latter biomarkers having the highest areas-under- curve for predicting CMD.Conclusions:Coronary microvascular dysfunction is common in patients with COVID-19 and is related to the severity of the infection. CMD may also explain the “cryptic” myocardial injury seen in patients with severe COVID-19 infection. | en_US |
dc.identifier.citation | Atıcı A, Çağ Y, Konal O, İrgi T, Bilgili ÜZ, Ağırbaşlı MA. Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection. Microcirculation. 2022 Apr 18:e12757. doi: 10.1111/micc.12757. Epub ahead of print. PMID: 35437863. | en_US |
dc.identifier.doi | 10.1111/micc.12757 | en_US |
dc.identifier.issn | 1549-8719 | en_US |
dc.identifier.pmid | 35437863 | en_US |
dc.identifier.scopus | 2-s2.0-85129600572 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | http://doi.org/10.1111/micc.12757 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2699 | |
dc.identifier.wos | WOS:000789845200001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Güvenç, Tolga Sinan | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Microcurcilation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS- COV-2 | en_US |
dc.subject | Coronary Microvascular Dysfunction | en_US |
dc.subject | Echocardiography | en_US |
dc.subject | Myocardial Injury | en_US |
dc.title | Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Microcirculation - 2022 - al kan - Coronary microvascular dysfunction is common in patients hospitalized with COVID‐19.pdf
- Boyut:
- 1.57 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: